Nicotine Dependence study: Text Message
Official title A Digital Intervention (ACT on Vaping App) for Vaping Cessation in Young Adult E-Cigarette Users
ClinicalTrials.gov ID: NCT06909500
What this study is testing
- What it's testing
- The study tests whether the ACT on Vaping app can help young adults stop using e‑cigarettes and other nicotine products.
- Who it's for
- Young adults who currently vape and want to quit.
- What's involved
- Participants will download the app, complete guided therapy sessions, and track their vaping habits on their phone.
- Time commitment
- The program lasts several weeks, with daily app use and periodic check‑ins via the phone.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 30. Healthy volunteers may be eligible.
You may be able to join if
- Age 18-30
- Current weekly user of e-cigarette product(s) for the last 30 days
- Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
- Experience downloading and using one or more apps on their smartphone
- Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app
You likely can't join if
- Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these...
- Member of the same household as another research participant
- Currently in prison
- Google voice number as sole phone number, due to its association with fraudulent study entry attempts
- Is ineligible per fraud prevention protocol
- Employees/family of investigator or study center
See the full eligibility criteria
- Age 18-30
- Current weekly user of e-cigarette product(s) for the last 30 days
- Has a smartphone; either an Android (running version 12 or higher) or iPhone (running iOS version 17 or higher, iPhone 11 or more recent)
- Experience downloading and using one or more apps on their smartphone
- Have a mobile data plan and/or access to WiFi to support the use of the ACT on Vaping app
- Has access to text messaging
- Has an email address
- United States (US) resident, with a US mailing address
- Willing to complete all study procedures
- Comfortable reading and writing in English
- Currently using other tobacco cessation treatments at the time of screening, including pharmacotherapy or behavioral support (note: use of these treatment is allowable during trial participation)
- Member of the same household as another research participant
- Currently in prison
- Google voice number as sole phone number, due to its association with fraudulent study entry attempts
- Is ineligible per fraud prevention protocol
- Employees/family of investigator or study center
The study team makes the final eligibility decision.
Where it is enrolling
- Seattle, Washington, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 30 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Seattle, Washington, United States. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.